EMA and EORTC multi-stakeholder workshop on soft tissue and bone sarcoma

The European Medicines Agency (EMA) and the European Organisation of Research and Treatment of Cancer (EORTC) are organising a multi-stakeholder workshop on soft tissue and bone sarcoma. It specifically addresses how we can develop new treatments in ultra-rare sarcomas, as a model for ultra-rare tumours.
This workshop brings together academia, learned societies, patients, non-profit organisations, and medicines regulators.